SpheriSome® Hb

Lead Participant: SPHERITECH LIMITED

Abstract

Blood substitutes are of immense importance in circumstances where immediate blood supply is required but cannot be supplied through traditional blood transfusion (e.g. in trauma units, haemophilia, cases where blood can be contaminated by disease, during transplant surgery, or on the battlefield). This project will explore the technical feasibility of developing SpheriSome® Hb – an artificial haemoglobin-based oxygen carrier.

Lead Participant

Project Cost

Grant Offer

SPHERITECH LIMITED £99,687 £ 69,781
 

Participant

INNOVATE UK

Publications

10 25 50